Endocrinology, Diabetes & Metabolism Case Reports (Jul 2021)

Deterioration of pituitary function without relapse after steroid therapy for IgG4-related hypophysitis

  • Nobuyuki Nishi,
  • Ken Takeshima,
  • Shuhei Morita,
  • Hiroshi Iwakura,
  • Masahiro Nishi,
  • Takaaki Matsuoka

DOI
https://doi.org/10.1530/EDM-21-0029
Journal volume & issue
Vol. 1, no. 1
pp. 1 – 6

Abstract

Read online

IgG4-related hypophysitis is an autoimmune hypophysitis associated with IgG4-related disease. Swelling of the pituitary gland is responsive to steroid therapy, but the prognosis of pituitary function after the treatment remains unclear. The present case implies that transiently improved pituitary function can re-worsen during long-term follow-up in IgG4-related hypophysitis. A 71-year-old male patient with IgG4-related hypophysitis visited a nearby hospital with malaise, anorexia, and polyuria. Pituitary dysfunction was suspected, so he was referred to our hospital for further examination. Imaging studies and laboratory data showed swelling of the pituitary gland and panhypopituitarism, which dramatically improved following steroid therapy. There was no evidence of relapsing IgG4-related disease during prednisolone tapering. Pituitary function was examined after 4 years under treatment with low-dose prednisolone; surprisingly, anterior pituitary function had worsened again. Our case suggests a need for continuous monitoring of pituitary function after steroid therapy for IgG4-related hypophysitis. This report illustrates the natural course of pituitary function in IgG4-related hypophysitis and may be informative when considering the introduction of steroid therapy.